ISPOR Europe 2024 News Center
Explore the news and reporting from ISPOR Europe 2024 in the News Center with curated stories on cutting-edge topics from the conference.
Inside the Third Plenary: Balancing Costs and Evidence for Affordable Medicines and Stronger EU HTA
2024/11/22 | The Evidence Base
ISPOR Europe 2024 – Inside the Second Plenary: Ensuring Readiness for EU HTAR
2024/11/19 | The Evidence Base
ISPOR Europe 2024 – Inside the First Plenary: Navigating Evidence-Price Challenges for Patient Access
2024/11/18 | The Evidence Base
Countdown to ISPOR Europe 2024
2024/11/14 | The Evidence Base
Spotlight on ISPOR Europe 2024: An Interview With ISPOR's Rob Abbott and Laura Pizzi
2024/11/04 | The Evidence Base
Preview of ISPOR Europe Plenary Sessions
2024/10/03 | The Evidence Base
ISPOR Europe 2024 Plenaries and Speakers Announced
2024/09/23 | ISPOR
ISPOR Europe Program Published
2024/09/04 | ISPOR
Hotel Block Accommodations Open for ISPOR Europe
2024/09/04 | ISPOR
ISPOR Europe 2024: Generating Evidence Toward Health and Well-Being
The ISPOR Europe 2024 conference—Generating Evidence Toward Health and Well-Being—centers on the importance of scientific evidence in understanding and improving the health and well-being of people across the globe. News from the conference will be posted as stories are published.
ISPOR Europe 2024 Daily Round-Ups: Day 3 [The Evidence Base]
Inside the Third Plenary: Balancing Costs and Evidence for Affordable Medicines and Stronger EU HTA [The Evidence Base]
[Video] Final Impressions from ISPOR Europe 2024 [RTI(h)(s)]
Growth and Challenges in Cross-Border Collaborations [Navlin Daily]
First Medicare Negotiation Round was "Outcomes Driven, not Process Driven" [Navlin Daily]
ISPOR Europe 2024 Daily Round-Ups: Day 2 [The Evidence Base]
Inside the Second Plenary: Ensuring Readiness for EU HTAR [The Evidence Base]
Upcoming Danish Medicines Council Chair Says EMA Should "Step Up"on Confirmatory Trials [Navlin Daily]
Belgian Health Official Worries Uncertainty Can be Seen as "Negotiating Chip" [Navlin Daily]
Companies Working "at Risk" Due to Lack of Transparency in HTAR - Roche Head [Navlin Daily]
Cost-Saving Potential of RDP Change in EU Legislation "Quite Limited" - TLV Director [Navlin Daily]
ISPOR Europe 2024 Daily Round-Ups: Day 1 [The Evidence Base]
Inside the First Plenary: Navigating Evidence-Price Challenges for Patient Access [The Evidence Base]
ISPOR Europa: se Avanza en Acuerdos de Compra, Falta Transparencia [DiarioFarma]
Round-Up of the ISPOR Real-World Evidence Summit 2024 [The Evidence Base]
Countdown to ISPOR Europe 2024 [The Evidence Base]
Navigating the ISPOR Europe 2024 Conference Program – Focus on Real-World Data and Real-World Evidence [The Evidence Base]
ISPOR Europe 2024: Navigating the Conference Program – Focus on Drug Pricing [The Evidence Base]
ISPOR Europe 2024: Navigating the Conference Program – Focus on Artificial Intelligence [The Evidence Base]
ISPOR Europe 2024: Navigating the Conference Program – Focus on Health Equity [The Evidence Base]
ISPOR Europe 2024: Navigating the Conference Program – Focus on Patient Centricity [The Evidence Base]
ISPOR Europe 2024: Navigating the Conference Program – Focus on Health Technology Assessment and Health Policy [The Evidence Base]
ISPOR Real-World Evidence Summit 2024: Event Preview [The Evidence Base]
Spotlight on ISPOR Europe 2024: An Interview with ISPOR's Rob Abbott and Laura Pizzi [The Evidence Base]
New Study Shows NICE Advice Support Can Reduce Appraisal Timelines by 3 Months [WiredGov]
Preview of ISPOR Europe 2024 Plenary Sessions [The Evidence Base]
First Look at the ISPOR Europe 2024 Conference Program [The Evidence Base]
ISPOR’s New Strategic Plan Underscores Importance of Accessible, Effective, Efficient, and Affordable Global Healthcare [The Evidence Base]
ISPOR and ACCESS Forum Announce Collaboration [Fox 40]
Planning Ahead and Key Dates for ISPOR Europe 2024 [The Evidence Base]
Photo Gallery
Additional News From the Conference
Cognito Therapeutics Presents Early-Stage Cost-Effectiveness Analysis of Spectris™ Therapy in Alzheimer’s Disease at ISPOR Europe 2024 [Business Wire]
Partners4Access Will Present Three Thought Provoking Posters at ISPOR Europe 2024 in Barcelona [Partners4Access]
Data Leaders Network to Attend ISPOR Europe 2024 [Data Leaders Network]
ISPOR Europe 2024: Driving Health Innovation [ESiOR]
IHE (The Swedish Institute for Health Economics) at ISPOR Europe in Barcelona [iHE]
Healthcare Economists' ISPOR Europe Panels [Healthcare Economist]
Meet the Quantify Team at ISPOR Europe! [Quantify]
Join AMICULUM at ISPOR Europe 2024 [PMLiVE]
Flatiron Health Announces Research to be Presented at ISPOR Europe 2024 Conference [Yahoo! Finance]
Syneos Health Attends ISPOR Europe [Syneos]
Discover Cencora at ISPOR Europe [Cencora]
RTI Health Solutions Attending ISPOR Europe 2024 [RTI Solutions]
Curta Presenting at ISPOR Europe 2024 [Curta]
Evidera Attending ISPOR Europe [Evidera]
MedEngine Attending ISPOR Europe [MedEngine]
Mtech Access Exhibiting at ISPOR in Europe [PMLive]
AcuCort Presents Study Results at the ISPOR Scientific Conference in Barcelona [AcuCort]
AHI to Unveil Cost-Saving Health Tech at ISPOR Europe [TipRanks]
HEOR News Desk
ISPOR News Webpage
Thank You to ISPOR Europe 2024 Media Partners:
A special thank you to ISPOR Europe 2024's Media Partners—The Evidence Base, Journal of Medical Economics, and PharmaBoardroom—and to all the media outlets who are reporting on the conference.
Disclaimer:
The reporting on ISPOR Europe 2024 from external news sources reflects the views of the authors/media outlets and is not endorsed by ISPOR.